|
Post by kball on Jan 21, 2017 12:35:19 GMT -5
If only the sales reps could get 10 uninterrupted hours with each endo to explain the best way for vastly different patients used to vastly different eating habits, to correctly use afrezza
And then follow up with additional 5 hours for each endo as their patients experience whatever keeps them from renewing and attempt to adjust dose
|
|
|
Post by slugworth008 on Jan 21, 2017 13:21:06 GMT -5
Low priced stock options are the driving force for new employees to MNKD. And from my past experience companies do (with a whisper or wink) tip-off potential employees that something big is about to happen. So, if we see the sales force positions filled in record time and a couple more senior level people join MNKD, then its on baby. I'm all in favor of MNKD offering their employees stock options as payment instead of traditional salaries. In my opinion, it provides incentive for employees to perform and make the company grow, which will in turn make their (and our) personal financial situations grow. However, I think MNKD is offering low priced stock options to their people because the company simply doesn't have the cash to afford such a large staff these days and they want to avoid increasing their cash burn rate through expensive salaries. I'm not a believer that simply because they offer stock options, good things loom. They have no other option and it doesn't mean a thing. Reading the tea leaves can be dangerous. There has been a lot of prognosticating lately about how everything is lining up for greatness. Meanwhile we're at a share price of .65 and weekly scripts of 200. It's comical and it's also eerily reminiscent of what we had just after the Sanofi deal and we all know how that turned out. There's been a lot of prognosticating for the past 3 years - IMO
|
|
|
Post by mnholdem on Jan 21, 2017 13:48:09 GMT -5
Every new patient ought to be urged to watch the videos from afrezzauser. He experimented with dosages until he dialed in what works for him. I think Afrezza is so effective that it takes a paradigm shift to understand it. Reminds me of my first experience driving a Porsche. For years I was into muscle cars (i.e. '67 GTO) and some powerful classics (favorite being my '61 Thunderbird). I street raced and learned how to handle some of these powerful cars pretty decently, I thought. Then I drove a Porsche for the first time. It was so quick and incredibly responsive that I found myself over correcting and nearly crashed it a few times. Afrezza is is very much the same as a Porsche. Fast. Responsive. Maybe even a bit frightening for first-time users. The difference, of course, is that you're not likely to crash if you over-react. I wonder if this analogy might work for marketing, encouraging patients to take Afrezza for a test drive.
|
|
|
Post by falconquest on Jan 21, 2017 14:59:49 GMT -5
Every new patient ought to be urged to watch the videos from afrezzauser. He experimented with dosages until he dialed in what works for him. I think Afrezza is so effective that it takes a paradigm shift to understand it. Reminds me of my first experience driving a Porsche. For years I was into muscle cars (i.e. '67 GTO) and some powerful classics (favorite being my '61 Thunderbird). I street raced and learned how to handle some of these powerful cars pretty decently, I thought. Then I drove a Porsche for the first time. It was so quick and incredibly responsive that I found myself over correcting and nearly crashed it a few times. Afrezza is is very much the same as a Porsche. Fast. Responsive. Maybe even a bit frightening for first-time users. The difference, of course, is that you're not likely to crash if you over-react. I wonder if this analogy might work for marketing, encouraging patients to take Afrezza for a test drive. Perhaps there's a marketing idea there. Test drive Afrezza for 90 days. If you aren't convinced it's the best mealtime insulin available, Mannkind will refund your money.
|
|